Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

Buijsers B, Yanginlar C, Maciej-Hulme ML, de Mast Q, van der Vlag J.

[Promising and potential drugs for the treatment of COVID-19]

Moneriz C, Castro-Salguedo C.

Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis

Das RR, Jaiswal N, Dev N, Jaiswal N, Naik SS, Sankar J.

Treatment Options for COVID-19: A Review

Ali MJ, Hanif M, Haider MA, Ahmed MU, Sundas F, Hirani A, Khan IA, Anis K, Karim AH.

Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol

Capochiani E, Frediani B, Iervasi G, Paolicchi A, Sani S, Roncucci P, Cuccaro A, Franchi F, Simonetti F, Carrara D, Bertaggia I, Nasso D, Riccioni R, Scolletta S, Valente S, Conticini E, Gozzetti A, Bocchia M.

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion

Farhat RM, Mousa MA, Daas EJ, Glassberg MK.

Convalescent plasma therapy in a pregnant COVID-19 patient with a dramatic clinical and imaging response: A case report

Jafari R, Jonaidi-Jafari N, Dehghanpoor F, Saburi A.

Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19

Afsin A, Ecemis K, Asoglu R.

Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis

Ullah W, M Abdullah H, Roomi S, Sattar Y, Almas T, Narayana Gowda S, Saeed R, Mukhtar M, Ahmad A, Oliver T, Alraies MC, Haas DC, Fischman DL.

Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?

Li C, Cheng G.

Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches

Dong R, Chu Z, Yu F, Zha Y.

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus

de Miranda Santos IKF, Costa CHN.

Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome

Kaniusas E, Szeles JC, Kampusch S, Alfageme-Lopez N, Yucuma-Conde D, Li X, Mayol J, Neumayer C, Papa M, Panetsos F.

DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Smelcerovic A, Kocic G, Gajic M, Tomovic K, Djordjevic V, Stankovic-Djordjevic D, Anderluh M.

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use

Chen Y, Shen T, Zhong L, Liu Z, Dong X, Huang T, Wang Q, Xiao H.

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

Zhuang W, Fan Z, Chu Y, Wang H, Yang Y, Wu L, Sun N, Sun G, Shen Y, Lin X, Guo G, Xi S.

The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19

Xu Y, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, Lau E, Cao H.

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2

Rohaim MA, Munir M.

Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?

Kothari A, Singh V, Nath UK, Kumar S, Rai V, Kaushal K, Omar BJ, Pandey A, Jain N.

Cancer pain treatment during the COVID-19 pandemic: institutional recommendations

Sousa AM, Grigio TR, Ashmawi HA, Ribeiro J√∫nior U.

Preferential use of dexamethasone for fetal lung maturation in severe COVID-19

Dellapiana G, Naqvi M, Leggett C, Tholemeier L, Burwick RM.

High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial

Maskin LP, Olarte GL, Palizas F Jr, Velo AE, Lurbet MF, Bonelli I, Baredes ND, Rodríguez PO.

Rapid Review of SARS-CoV-1 and SARS-CoV-2 Viability, Susceptibility to Treatment, and the Disinfection and Reuse of PPE, Particularly Filtering Facepiece Respirators

Derraik JGB, Anderson WA, Connelly EA, Anderson YC.

The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey

Noale M, Trevisan C, Maggi S, Antonelli Incalzi R, Pedone C, Di Bari M, Adorni F, Jesuthasan N, Sojic A, Galli M, Giacomelli A, Molinaro S, Bianchi F, Mastroianni C, Prinelli F, Group OBOTEW.

The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy

Borlongan MC, Borlongan MC, Sanberg PR.

Emerging Treatment Options of Regenerative Medicine in Severe Corona Virus/COVID 19 Infections

Kumar A, Ghosh SB.

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

Walsh EE, Frenck R, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Thompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Sahin U, Gruber WC.

Hydroxychloroquine is protective to the heart, not Harmful: A systematic review

Prodromos CC.

Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations

Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O.

Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study

Gormez S, Ekicibasi E, Degirmencioglu A, Paudel A, Erdim R, Gumusel HK, Eroglu E, Tanboga IH, Dagdelen S, Sariguzel N, Kirisoglu CE, Pamukcu B.

Telemental health for child trauma treatment during and post-COVID-19: Limitations and considerations

Racine N, Hartwick C, Collin-Vézina D, Madigan S.

The role of the urologist, BCG vaccine administration, and SARS-CoV-2: An overview

Brooks NA, Narayan V, Hegarty PK, Zafirakis H, Han XY, Kamat AM.

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Sridhar AR, Chatterjee NA, Saour B, Nguyen D, Starnes EA, Johnston C, Green ML, Roth GA, Poole JE.

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

Pizzorno A, Padey B, Julien T, Trouillet-Assant S, Traversier A, Errazuriz-Cerda E, Fouret J, Dubois J, Gaymard A, Lescure FX, Dulière V, Brun P, Constant S, Poissy J, Lina B, Yazdanpanah Y, Terrier O, Rosa-Calatrava M.

Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity

Yarmarkovich M, Warrington JM, Farrel A, Maris JM.

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, Franceschini E, Cuomo G, Orlando G, Borghi V, Santoro A, Di Gaetano M, Puzzolante C, Carli F, Bedini A, Corradi L, Fantini R, Castaniere I, Tabbì L, Girardis M, Tedeschi S, Giannella M, Bartoletti M, Pascale R, Dolci G, Brugioni L, Pietrangelo A, Cossarizza A, Pea F, Clini E, Salvarani C, Massari M, Viale PL, Mussini C.

Can tocilizumab calm the cytokine storm of COVID-19?

Schulert GS.

Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19

Liu C, von Brunn A, Zhu D.

Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation?

Razdan K, Singh K, Singh D.

BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?

Rajarshi K, Chatterjee A, Ray S.

Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?

Iboi EA, Ngonghala CN, Gumel AB.

Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence

Cairoli E, Espinosa G.

Pre- and post-treatment chest CT changes in a patient with COVID-19

Fu B, Qian K, Fu X.

Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?

Lasheras I, Santab√°rbara J.

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation

Bhattacharya M, Sharma AR, Patra P, Ghosh P, Sharma G, Patra BC, Saha RP, Lee SS, Chakraborty C.

Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19

El Rhazi K, Adarmouch L.

Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model

Cui C, Zhang M, Yao X, Tu S, Hou Z, Jie En VS, Xiang X, Lin J, Cai T, Shen N, Song C, Qiao J, Zhang S, Li H, Liu D.

Analysis on herbal medicines utilized for treatment of COVID-19

Luo L, Jiang J, Wang C, Fitzgerald M, Hu W, Zhou Y, Zhang H, Chen S.

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight

He C, Qin M, Sun X.

Cancer research, treatment, and COVID-19

Curley SA, Currell F, Krishnan S, Krpetic Z.

Favipiravir tautomerism: a theoretical insight

Antonov L.

Willingness to pay for a COVID-19 vaccine high in Chile

ICER update to pricing models of remdesivir for COVID-19

Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism

Xu J, Pan LJ, Jia CS.

Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies

Baildya N, Ghosh NN, Chattopadhyay AP.

Quantum mechanical simulation of Chloroquine drug interaction with C60 fullerene for treatment of COVID-19

Bagheri Novir S, Aram MR.

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment

Aksel G, Islam MM, Aslan T, Eroglu SE.

Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences

Zaheer T, Waseem M, Waqar W, Dar HA, Shehroz M, Naz K, Ishaq Z, Ahmad T, Ullah N, Bakhtiar SM, Muhammad SA, Ali A.

Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU

Pasquini Z, Montalti R, Temperoni C, Canovari B, Mancini M, Tempesta M, Pimpini D, Zallocco N, Barchiesi F.

Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking

Udrea AM, Avram S, Nistorescu S, Pascu ML, Romanitan MO.

COVID-19 epidemic monitoring after non-pharmaceutical interventions: the use of time-varying reproduction number in a country with a large migrant population

Al Wahaibi A, Al Manji A, Al Maani A, Al Rawahi B, Al Harthy K, Alyaquobi F, Al-Jardani A, Petersen E, Al-Abri S.

CORTICOSTEROIDS IN THE TREATMENT OF SEVERE COVID-19 LUNG DISEASE: THE PULMONOLOGY PERSPECTIVE FROM THE FIRST UNITED STATES EPICENTER

Macauley P, Martin A, Epelbaum O.

Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition

Takahashi H, Iwasaki Y, Watanabe T, Ichinose N, Okada Y, Oiwa A, Kobayashi T, Moriya M, Oda T.

A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island

Dubernet A, Larsen K, Masse L, Allyn J, Foch E, Bruneau L, Maillot A, Lagrange-Xelot M, Thomas V, Jaffar-Bandjee MC, Gauzere L, Raffray L, Borsu K, Dibernardo S, Renaud S, André M, Moreau D, Jabot J, Coolen-Allou N, Allou N.

Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays

DomBourian MG, Annen K, Huey L, Andersen G, Merkel PA, Jung S, Dominguez SR, Knight V.

Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial

Alamdari DH, Moghaddam AB, Amini S, Keramati MR, Zarmehri AM, Alamdari AH, Damsaz M, Banpour H, Yarahmadi A, Koliakos G.

SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine

Singh Tomar PP, Arkin IT.

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

Rayner CR, Dron L, Park JJH, Decloedt EH, Cotton MF, Niranjan V, Smith PF, Dodds MG, Brown F, Reis G, Wesche D, Mills EJ.

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study

Abd-Elsalam S, Esmail ES, Khalaf M, Abdo EF, Medhat MA, Abd El Ghafar MS, Ahmed OA, Soliman S, Serangawy GN, Alboraie M.

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

Akram J, Azhar S, Shahzad M, Latif W, Khan KS.

Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein

Rakib A, Sami SA, Mimi NJ, Chowdhury MM, Eva TA, Nainu F, Paul A, Shahriar A, Tareq AM, Emon NU, Chakraborty S, Shil S, Mily SJ, Ben Hadda T, Almalki FA, Emran TB.

The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients

Bakhshaliyev N, Uluganyan M, Enhos A, Karacop E, Ozdemir R.

Effect of Remdesivir on Patients with COVID-19: A Network Meta-Analysis of Randomized Control Trials

Yokoyama Y, Briasoulis A, Takagi H, Kuno T.

Bringing into Focus Treatment Limitation and DNACPR Decisions: How COVID-19 has Changed Practice

Coleman JJ, H Botkai A, Marson EJ, Evison F, Atia J, Wang J, Gallier S, Speakman J, Pankhurst T.

Are Medicinal Plants an Alternative Strategy to Combat COVID-19?

Prasher P, Sharma M, Gupta G, Chellappan DK, Dua K.

Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic

Khadka S, Yuchi A, Shrestha DB, Budhathoki P, Al-Subari SMM, Ziad Alhouzani TM, Anwar Butt I.

Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19

Majolo F, da Silva GL, Vieira L, Timmers LFSM, Laufer S, Goettert MI.

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

Feng L, Wang Q, Shan C, Yang C, Feng Y, Wu J, Liu X, Zhou Y, Jiang R, Hu P, Liu X, Zhang F, Li P, Niu X, Liu Y, Zheng X, Luo J, Sun J, Gu Y, Liu B, Xu Y, Li C, Pan W, Zhao J, Ke C, Chen X, Xu T, Zhong N, Guan S, Yuan Z, Chen L.

Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond

Drake C, Yu J, Lurie N, Kraemer K, Polsky D, Chaiyachati KH.

White paper on Ivermectin as a potential therapy for COVID-19

Vora A, Arora VK, Behera D, Tripathy S.

Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009

Rojek AM, Martin GE, Horby PW.

Are Myths and Preconceptions Preventing us from Applying Ionic Liquid Forms of Antiviral Medicines to the Current Health Crisis?

Shamshina JL, Rogers RD.

Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy

Bertuzzi AF, Marrari A, Gennaro N, Cariboni U, Ciccarelli M, Giordano L, Quagliuolo VL, Santoro A.

Novel Antiviral Strategies in the Treatment of COVID-19: A Review

Chen SJ, Wang SC, Chen YC.

Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy

French J, Deshpande S, Evans W, Obregon R.

Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits

Bellavite P, Donzelli A.

The host targeting effect of chloroquine in malaria

Coban C.

Advancing COVID-19 vaccines - avoiding different regulatory standards for different vaccines and need for open and transparent data sharing

Petersen E, Zumla A.

Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19

Ikonomidis I, Pavlidis G, Katsimbri P, Lambadiari V, Parissis J, Andreadou I, Tsoumani M, Boumpas D, Kouretas D, Iliodromitis E.

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial

Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators.

Efficacy of Remdesivir in COVID-19

McCreary EK, Angus DC.

Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm

Wiemer AJ.

ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review

Mostafa-Hedeab G.

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review

Acharya Y, Sayed A.

Hemoperfusion as a Supportive Treatment in a COVID-19 Patient with Late Pulmonary Thromboembolism: A Case Report

Moradi H, Abbasi S.

A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19

Hashemian SM, Farhadi T, Velayati AA.

Patterns of acute surgical inflammatory processes presentation of in the COVID-19 outbreak (PIACO Study): Surgery may be the best treatment option

Guadalajara H, Muñoz de Nova JL, Fernandez Gonzalez S, Yiasemidou M, Recarte Rico M, Juez LD, García Septiem J, Galindo Jara P, García Virosta M, Lobo Martínez E, Martín-Pérez E, García-Olmo D; PIACO Collaboration Group.

Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study

Vaughn VM, Gandhi T, Petty LA, Patel PK, Prescott HC, Malani AN, Ratz D, McLaughlin E, Chopra V, Flanders SA.

Prescribing in COVID-19 patients: Should we take into account inflammation?

Marzolini C, Battegay M, Sendi P, Back DJ.

[Interdisciplinary multimodal pain therapy under the protective measures of the COVID-19 pandemic : Analysis and progress report]

Luchting B.

Steroids in COVID-19: An overview

Chatterjee K, Wu CP, Bhardwaj A, Siuba M.

Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out

De Franceschi L, Costa E, Dima F, Morandi M, Olivieri O.

Evaluating the Efficacy of Therapies in COVID-19 Patients

Lin DY, Zeng D, Eron JJ.

Ruxolitinib in COVID-19 Hyperinflammation and Haematologic Malignancies

La Rosée F, La Rosée P.

ACE2, Metformin, and COVID-19

Malhotra A, Hepokoski M, McCowen KC, Y-J Shyy J.

Photodynamic and Sonodynamic Therapy of Acute Hypoxemic Respiratory Failure in Patients with COVID-19

Kipshidze N, Yeo N, Kipshidze N.

The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?

Mahooti M, Miri SM, Abdolalipour E, Ghaemi A.

Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges

Parvathaneni V, Gupta V.

Flu Vaccination Urged During COVID-19 Pandemic

Jaklevic MC.

Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic

Grohskopf LA, Liburd LC, Redfield RR.

Early Use of Tocilizumab May Prevent Clinical Deterioration in Select COVID-19 Patients: A Case Series

Hitawala A, Kumar S, Gopalakrishna KV.

Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis

Walz L, Cohen AJ, Rebaza AP, Vanchieri J, Slade MD, Dela Cruz CS, Sharma L.

Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience

Joyner MJ, Senefeld JW, Klassen SA, Mills JR, Johnson PW, Theel ES, Wiggins CC, Bruno KA, Klompas AM, Lesser ER, Kunze KL, Sexton MA, Diaz Soto JC, Baker SE, Shepherd JRA, van Helmond N, van Buskirk CM, Winters JL, Stubbs JR, Rea RF, Hodge DO, Herasevich V, Whelan ER, Clayburn AJ, Larson KF, Ripoll JG, Andersen KJ, Buras MR, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Paneth NS, Fairweather D, Wright RS, Carter RE, Casadevall A.

Vaccine optimization for COVID-19, who to vaccinate first?

Matrajt L, Eaton J, Leung T, Brown ER.

Hospital length of stay for severe COVID-19: implications for Remdesivir's value

Anderson M, Bach P, Baldwin MR.

Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates

Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, Lopman B, Handel A, Koelle K.

Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture

Risner KH, Tieu KV, Wang Y, Bakovic A, Alem F, Bhalla N, Nathan S, Conway DE, Macklin P, Narayanan A.

SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with non-severe disease

Gniadek TJ, Thiede JM, Matchett WE, Gress AR, Pape KA, Jenkins MK, Menachery VD, Langlois RA, Bold TD.

Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations

Bradfute SB, Ye C, Clarke EC, Kumar S, Timmins GS, Deretic V.

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia

Mikulska M, Nicolini LA, Signori A, Di Biagio A, Sepulcri C, Russo C, Dettori S, Berruti M, Sormani MP, Giacobbe DR, Vena A, De Maria A, Dentone C, Taramasso L, Mirabella M, Magnasco L, Mora S, Delfino E, Toscanini F, Balletto E, Alessandrini AI, Baldi F, Briano F, Camera M, Dodi F, Ferrazin A, Labate L, Mazzarello G, Pincino R, Portunato F, Tutino S, Barisione E, Bruzzone B, Orsi A, Schenone E, Rosseti N, Sasso E, Da Rin G, Pelosi P, Beltramini S, Giacomini M, Icardi G, Gratarola A, Bassetti M.

Risk-benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19

Dhanasekaran S, Vajravelu LK, Venkatesalu V.

Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?

Stevenson A, Kirresh A, Conway S, White L, Ahmad M, Little C.

Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo

Weston S, Coleman CM, Haupt R, Logue J, Matthews K, Li Y, Reyes HM, Weiss SR, Frieman MB.

Bowel ulceration following tocilizumab administration in a COVID-19 patient

Bruce-Hickman D, Sajeed SM, Pang YH, Seow CS, Chen W, Gulati Kansal M.

The rush to create a covid-19 vaccine may do more harm than good

Torreele E.

Covid-19: Russia approves vaccine without large scale testing or published results

Mahase E.

Covid-19: Pre-purchasing vaccine-sensible or selfish?

Torjesen I.

High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab

Conticini E, Franchi F, Bennett D, Valente S, Mazzei MA, Bargagli E, Volterrani L, Scolletta S, Frediani B.

Response to: 'High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab' by Conticini et al

Ramiro S, Mostard R, Landewé RB.

Could Sumac Be Effective on COVID-19 Treatment?

Korkmaz H.

Use of Azithromycin in COVID-19: A Cautionary Tale

Kow CS, Hasan SS.

Pharmacological treatments of COVID-19

Sahebnasagh A, Avan R, Saghafi F, Mojtahedzadeh M, Sadremomtaz A, Arasteh O, Tanzifi A, Faramarzi F, Negarandeh R, Safdari M, Khataminia M, Rezai Ghaleno H, Habtemariam S, Khoshi A.

Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review

Del Castillo R, Martinez D, Sarria GJ, Pinillos L, Garcia B, Castillo L, Carhuactocto A, Giordano FA, Sarria GR.

Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis

Kumar N, Awasthi A, Kumari A, Sood D, Jain P, Singh T, Sharma N, Grover A, Chandra R.

Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development

Begum J, Mir NA, Dev K, Buyamayum B, Wani MY, Raza M.

Beta-adrenergic Blockers as a Potential Treatment for COVID-19 Patients

Vasanthakumar N.

Phytotherapeutic options for the treatment of COVID-19: A concise viewpoint

Din M, Ali F, Waris A, Zia F, Ali M.

Exploring the SARS-CoV-2 structural proteins for Multi-Epitope vaccine development: an in-silico approach

Kumar A, Kumar P, Saumya KU, Kapuganti SK, Bhardwaj T, Giri R.

Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy

Naeem S, Gohh R, Bayliss G, Cosgrove C, Farmakiotis D, Merhi B, Morrissey P, Osband A, Bailey JA, Sweeney J, Rogers R.

Repurposing calcium channel blockers as antiviral drugs

Jayaseelan VP, Paramasivam A.

Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study

Vannucchi AM, Sordi B, Morettini A, Nozzoli C, Poggesi L, Pieralli F, Bartoloni A, Atanasio A, Miselli F, Paoli C, Loscocco GG, Fanelli A, Para O, Berni A, Tassinari I, Zammarchi L, Maggi L, Mazzoni A, Scotti V, Falchetti G, Malandrino D, Luise F, Millotti G, Bencini S, Capone M, Piccinni MP, Annunziato F, Guglielmelli P; RUXO-COVID Study Group.

Protective potential of expectorants against COVID-19

Esam Z.

Is ocular toxicity expected in chloroquine/hydroxychloroquine prescription as a therapeutic or prophylactic option in COVID-19?

Bagheri M, Rashe Z, Ahur MH, Eidizadeh M.

COVID-19 and remdesivir in pediatric patients: the invisible part of the iceberg

Yalçın N, Demirkan K.

Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin

Hosseini A, Bahramnezhad F.

Effectiveness of remdesivir for the treatment of hospitalized Covid-19 persons: a network meta-analysis

Jiang Y, Chen D, Cai D, Yi Y, Jiang S.

Role of probiotics to combat viral infections with emphasis on COVID-19

Sundararaman A, Ray M, Ravindra PV, Halami PM.

Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial

Sadeghi A, Ali Asgari A, Norouzi A, Kheiri Z, Anushirvani A, Montazeri M, Hosamirudsai H, Afhami S, Akbarpour E, Aliannejad R, Radmard AR, Davarpanah AH, Levi J, Wentzel H, Qavi A, Garratt A, Simmons B, Hill A, Merat S.

Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial

Abbaspour Kasgari H, Moradi S, Shabani AM, Babamahmoodi F, Davoudi Badabi AR, Davoudi L, Alikhani A, Hedayatizadeh Omran A, Saeedi M, Merat S, Wentzel H, Garratt A, Levi J, Simmons B, Hill A, Tirgar Fakheri H.

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen

Pareek A, Bhandari S, Mehta RT.

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, Ji N, Zheng Y, Chen X, Shi L, Wu M, Deng K, Wei J, Wang X, Cao Y, Yan J, Feng G.

Vitamin D can be effective on the prevention of COVID-19 complications: A narrative review on molecular aspects

Shiravi AA, Saadatkish M, Abdollahi Z, Miar P, Khanahmad H, Zeinalian M.

[Effects on the integrated treatment of colorectal cancer patients during COVID-19 epidemic in China: a cross-sectional study]

Yang Y, Gao ZY, Chen YK, Wang HY, Chen JJ, Song C, Gu J.

The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients

Marcello A, Civra A, Milan Bonotto R, Nascimento Alves L, Rajasekharan S, Giacobone C, Caccia C, Cavalli R, Adami M, Brambilla P, Lembo D, Poli G, Leoni V.

Covid-19 Pandemic: a frontline hospital reorganization to cope with therapeutic and diagnostic emergency

De Filippis G, Cavazzana L, Gimigliano A, Piacenza M, Vimercati S.

Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees

Farooqi FI, Morgan RC, Dhawan N, Dinh J, Yatzkan G, Michel G.

Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia

Beyls C, Martin N, Hermida A, Abou-Arab O, Mahjoub Y.

MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale

Marik PE, Kory P, Varon J, Iglesias J, Meduri GU.

Anticoagulant treatment in COVID-19: a narrative review

Carfora V, Spiniello G, Ricciolino R, Di Mauro M, Migliaccio MG, Mottola FF, Verde N, Coppola N; Vanvitelli COVID-19 group.

[COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey]

Janda A, Schuetz C, Heeg M, Minden K, Hedrich CM, Kallinich T, Hinze C, Schulz A, Speth F.

Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities

Wang EA, Zenilman J, Brinkley-Rubinstein L.

Hydroxychloroquine for treatment of non-severe COVID-19 patients; systematic review and meta-analysis of controlled clinical trials

Elsawah HK, Elsokary MA, Elrazzaz MG, ElShafey AH.

Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19

Laroye C, Gibot S, Huselstein C, Bensoussan D.

Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy

Palamenghi L, Barello S, Boccia S, Graffigna G.

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia

Tatar E, Karatas M, Bozaci I, Ari A, Acar T, Simsek C, Yildirim AM, Yildirim O, Uslu A.

COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China

Ranard LS, Parikh SA, Kirtane AJ.

A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial

Hinks TSC, Barber VS, Black J, Dutton SJ, Jabeen M, Melhorn J, Rahman NM, Richards D, Lasserson D, Pavord ID, Bafadhel M.

Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19

Li R, Wu K, Li Y, Liang X, Tse WKF, Yang L, Lai KP.

Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia

Hernández A, Viñals M, Isidoro T, Vilás F.

Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19

Keller MJ, Kitsis EA, Arora S, Chen JT, Agarwal S, Ross MJ, Tomer Y, Southern W.

Considerations for the Treatment of Inflammatory Neuro-Ophthalmologic Disorders During the COVID-19 Pandemic

Martin Paez Y, Bennett JL, Subramanian PS, Pelak VS.

Possible role of ABCB1 in lysosomal accumulation of azithromycin in COVID-19 therapy

Scherrmann JM.

Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19

Chua KP, Conti RM.

Artificial Intelligence for Rapid Meta-Analysis: Case Study on Ocular Toxicity of Hydroxychloroquine

Michelson M, Chow T, Martin NA, Ross M, Tee Qiao Ying A, Minton S.

Study of the structural, chemical descriptors and optoelectronic properties of the drugs Hydroxychloroquine and Azithromycin

Ejuh GW, Fonkem C, Tadjouteu Assatse Y, Yossa Kamsi RA, Nya T, Ndukum LP, Ndjaka JMB.

Searching potential antiviral candidates for the treatment of the 2019 novel coronavirus based on DFT calculations and molecular docking

Sagaama A, Brandan SA, Ben Issa T, Issaoui N.

Data on chloroquine/hydroxychloroquine content in compounded oral suspension after filtration and centrifugation

Musazzi UM, Zanon D, Gennari CMG, Fortini M, Maximova N, Cilurzo F, Minghetti P.

Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance

Boutou AK, Pitsiou G, Kontakiotis T, Kioumis I.

Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients

H A, I S, J J B, A J, A R, H Z, S A R M, S M J M.

Clinical Outcomes of Early Treatment With Doxycycline for 89 High-Risk COVID-19 Patients in Long-Term Care Facilities in New York

Alam MM, Mahmud S, Rahman MM, Simpson J, Aggarwal S, Ahmed Z.

Prevention and Treatment Strategies for the Cardiology Department of a Non-COVID-19 Designated Hospital in the Post-Epidemic Period

Fan Q, Chen X, Lin Y, Wang Z.

Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable

Polkowski WP, Sędłak K, Rawicz-Pruszyński K.

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date

Si S, Teachey DT.

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice

Lu J, Lu G, Tan S, Xia J, Xiong H, Yu X, Qi Q, Yu X, Li L, Yu H, Xia N, Zhang T, Xu Y, Lin J.

Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2

Neves FS.

Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites

El Kantar S, Nehmeh B, Saad P, Mitri G, Estephan C, Mroueh M, Akoury E, Taleb RI.

COVID-19 Vaccine: A comprehensive status report

Kaur SP, Gupta V.

Sex-Based Vaccine Response in the Context of COVID-19

McCartney PR.

Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae

Hamm BS, Rosenthal LJ.

Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Villar J, Añón JM, Ferrando C, Aguilar G, Muñoz T, Ferreres J, Ambrós A, Aldecoa C, Suárez-Sipmann F, Thorpe KE, Jüni P, Slutsky AS; DEXA-COVID19 Network.

The aggressive surgical treatment and outcome of a colon cancer patient with COVID-19 in Wuhan, China

Gao J, Yang M, Liu L, Guo S, Li Y, Cheng C.

Impact of Tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients

Klopfenstein T, Zayet S, Lohse A, Selles P, Zahra H, Kadiane-Oussou NJ, Toko L, Royer PY, Balblanc JC, Gendrin V, Conrozier T; HNF Hospital Tocilizumab multidisciplinary team.

Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice

Case JB, Rothlauf PW, Chen RE, Kafai NM, Fox JM, Smith BK, Shrihari S, McCune BT, Harvey IB, Keeler SP, Bloyet LM, Zhao H, Ma M, Adams LJ, Winkler ES, Holtzman MJ, Fremont DH, Whelan SPJ, Diamond MS.

Approaches and Challenges in SARS-CoV-2 Vaccine Development

Dagotto G, Yu J, Barouch DH.

Baricitinib as treatment for COVID-19: friend or foe of the pancreas?

Cerda-Contreras C, Nuzzolo-Shihadeh L, Camacho-Ortiz A, Perez-Alba E.

Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al

Titanji BK, Farley MM, Schinazi RF, Marconi VC.

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Wu S, Zhong G, Zhang J, Shuai L, Zhang Z, Wen Z, Wang B, Zhao Z, Song X, Chen Y, Liu R, Fu L, Zhang J, Guo Q, Wang C, Yang Y, Fang T, Lv P, Wang J, Xu J, Li J, Yu C, Hou L, Bu Z, Chen W.

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19

Massalska M, Maslinski W, Ciechomska M.

A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease

Shiri I, Abdollahi H, Atashzar MR, Rahmim A, Zaidi H.

The impact of coronavirus disease (COVID-19) pandemic on intravitreal injections treatment for macular diseases: report from a referral hospital in Milan

Viola F, Milella P, Giuffrida FP, Ganci S, Invernizzi A.

Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?

Winn BJ.

Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19

Ouyang L, Gong J.

Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Salazar E, Christensen PA, Graviss EA, Nguyen DT, Castillo B, Chen J, Lopez BV, Eagar TN, Yi X, Zhao P, Rogers J, Shehabeldin A, Joseph D, Leveque C, Olsen RJ, Bernard DW, Gollihar J, Musser JM.

A Thermostable mRNA Vaccine against COVID-19

Zhang NN, Li XF, Deng YQ, Zhao H, Huang YJ, Yang G, Huang WJ, Gao P, Zhou C, Zhang RR, Guo Y, Sun SH, Fan H, Zu SL, Chen Q, He Q, Cao TS, Huang XY, Qiu HY, Nie JH, Jiang Y, Yan HY, Ye Q, Zhong X, Xue XL, Zha ZY, Zhou D, Yang X, Wang YC, Ying B, Qin CF.

Inclusion of pregnant women in COVID-19 vaccine development

Heath PT, Le Doare K, Khalil A.

Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

Miller J, Bruen C, Schnaus M, Zhang J, Ali S, Lind A, Stoecker Z, Stauderman K, Hebbar S.

Chemotherapy Treatment Modifications During the COVID-19 Outbreak at a Community Cancer Center in New York City

Lin DD, Meghal T, Murthy P, Mo L, D'Silva A, Huang Y, Xu Y.

The Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2

Glisic S, Perovic VR, Sencanski M, Paessler S, Veljkovic V.

[A case report on treatment of compartment syndrome with novel coronavirus pneumonia]

Yang P, Duan X, Wu Z, Zhou Q, Wu X.

[Expert consensus on prevention and treatment strategies for osteonecrosis of femoral head during the prevention and control of novel coronavirus pneumonia (2020)]

Bone Circulation And Osteonecrosis Professional Committee Shockwave Medical Specialty Committee Of Chinese Research Hospital Association.

A practical approach for the compassionate use of convalescent plasma in patients with severe COVID-19 in developing countries

Sabando Vélez BE, Plaza Meneses C, Felix M, Vanegas E, Mata VL, Romero Castillo H, Oliveros Alvear JW, Boloña E, Alejandra Posligua M, Layedra Bardi LR, Vera Paz C, Cherrez-Ojeda I.

Coronavirus disease 2019 in a psoriatic patient with concomitant chronic obstructive pulmonary disease under treatment with risankizumab

Kiss N, Lőrincz K, Medvecz M, Fésűs L, Csuha P, Hermányi Z, Wikonkál NM.

Treatment of pemphigus patients in the COVID-19 era: a specific focus on rituximab

Mahmoudi H, Tavakolpour S, Nili A, Salehi Farid A, Daneshpazhooh M, Rashidian M.

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay

Zeng C, Evans JP, Pearson R, Qu P, Zheng YM, Robinson RT, Hall-Stoodley L, Yount J, Pannu S, Mallampalli RK, Saif L, Oltz E, Lozanski G, Liu SL.

Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells

Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Lee CG, Elias JA, Campbell KS, Naik MT, Atwood WJ, Youssef E, Pachter JA, Navaraj A, Seyhan AA, Liang O, El-Deiry WS.

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate

Bangaru S, Ozorowski G, Turner HL, Antanasijevic A, Huang D, Wang X, Torres JL, Diedrich JK, Tian JH, Portnoff AD, Patel N, Massare MJ, Yates JR, Nemazee D, Paulson JC, Glenn G, Smith G, Ward AB.

Hospitalized COVID-19 Patients Treated With Convalescent Plasma in a Mid-size City in The Mid West

Hartman WR, Hess AS, Connor JP.

A Rational Design of a Multi-Epitope Vaccine Against SARS-CoV-2 Which Accounts for the Glycan Shield of the Spike Glycoprotein

Martin WR, Cheng F.

Tocilizumab exerts anti-inflammatory activity in six critically ill COVID-19 patients: a retrospective analysis

Qian S, An J, Qi F, Ye L, Chen Q, Liu X, Xie L, Li G.

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

Graham SP, McLean RK, Spencer AJ, Belij-Rammerstorfer S, Wright D, Ulaszewska M, Edwards JC, Hayes JWP, Martini V, Thakur N, Conceicao C, Dietrich I, Shelton H, Waters R, Ludi A, Wilsden G, Browning C, Bialy D, Bhat S, Stevenson-Leggett P, Hollinghurst P, Gilbride C, Pulido D, Moffat K, Sharpe H, Allen E, Mioulet V, Chiu C, Newman J, Asfor AS, Burman A, Crossley S, Huo J, Owens RJ, Carroll M, Hammond JA, Tchilian E, Bailey D, Charleston B, Gilbert SC, Tuthill TJ, Lambe T.

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies

Frederiksen LSF, Zhang Y, Foged C, Thakur A.

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, Shi PY.

Convalescent Plasma Therapy for COVID-19: State of the Art

Focosi D, Anderson AO, Tang JW, Tuccori M.

Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia

Di Tano G, De Maria R, Loffi M, Moschini L, Galeazzi G, Danzi GB.

Treatment of COVID-19 Patients in Italy: A Physician's Experience and Insights

Gilad V, Masoero G.

Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure

Rakedzon S, Khoury Y, Rozenberg G, Neuberger A.

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

Poran A, Harjanto D, Malloy M, Arieta CM, Rothenberg DA, Lenkala D, van Buuren MM, Addona TA, Rooney MS, Srinivasan L, Gaynor RB.

Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis

Zhang X, Cao D, Liu J, Zhang Q, Liu M.

A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019

Wang X, Xie P, Sun G, Zhao M, Deng Z, Zhou Y, Bao S.

The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19

Li Y, Bi L, Li Y, Hu X, Wang Q, Liang X, Yu X, Dong L, Xie Q.

Hanshiyi Formula, an approved medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study

Tian J, Yan S, Wang H, Zhang Y, Zheng Y, Wu H, Li X, Gao Z, Ai Y, Gou X, Zhang L, He L, Lian F, Liu B, Tong X.

Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks

Wooding DJ, Bach H.

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study

Ip A, Berry DA, Hansen E, Goy AH, Pecora AL, Sinclaire BA, Bednarz U, Marafelias M, Berry SM, Berry NS, Mathura S, Sawczuk IS, Biran N, Go RC, Sperber S, Piwoz JA, Balani B, Cicogna C, Sebti R, Zuckerman J, Rose KM, Tank L, Jacobs LG, Korcak J, Timmapuri SL, Underwood JP, Sugalski G, Barsky C, Varga DW, Asif A, Landolfi JC, Goldberg SL.

Scarcity of Hydroxychloroquine and Personal Protective Equipment (PPE) during Challenging Times of COVID-19 Pandemic

Bhargava S, Rathod D, Singh AK, Rokde R.

Drugs Repositioned for COVID-19 Are Routinely Prescribed by Dermatologists

Sharma A, Mhatre M, Goldust M.

Streamlined Poststroke Treatment Order Sets During the SARS-CoV-2 Pandemic: Simplifying While Not Compromising Care

Gioia LC, Poppe AY, Laroche R, Dacier-Falque T, Sévigny I, Daneault N, Deschaintre Y, Jacquin G, Stapf C, Odier C.

Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID-19

Pettit NN, Nguyen CT, Mutlu GM, Wu D, Kimmig L, Pitrak D, Pursell K.

Impact of COVID-19 pandemic on lung cancer treatment scheduling

Fujita K, Ito T, Saito Z, Kanai O, Nakatani K, Mio T.

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials

Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Zhang L, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Meng Z, Pan A, Yuan Z, Shen S, Guo W, Yang X.

Researchers Strive to Recruit Hard-Hit Minorities Into COVID-19 Vaccine Trials

Jaklevic MC.

An Inactivated Virus Candidate Vaccine to Prevent COVID-19

Mulligan MJ.

Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic

Dee EC, Mahal BA, Arega MA, D'Amico AV, Mouw KW, Nguyen PL, Muralidhar V.

Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review

Patel J, Patel R, Rodriguez LM, Blanco A, Hamza A.

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections

Mustafa MZ, Shamsuddin SH, Sulaiman SA, Abdullah JM.

The type I interferon response in COVID-19: implications for treatment

Lee JS, Shin EC.

Explaining the homogeneous diffusion of COVID-19 nonpharmaceutical interventions across heterogeneous countries

Sebhatu A, Wennberg K, Arora-Jonsson S, Lindberg SI.

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter

Gupta A, Malviya A.

Treatment of Colorectal Cancer and Other GI Cancers in the COVID-19 Pandemic

Chu E.

Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients

Hifumi T, Isokawa S, Otani N, Ishimatsu S.

Evaluation of retinotoxicity of COVID-19 treatment: hydroxychloroquine and lopinavir/ritonavir

Burgos-Blasco B, Güemes-Villahoz N, Vidal-Villegas B, Donate-Lopez J, Garcia-Feijoo J.

Vaccine hesitancy: the next challenge in the fight against COVID-19

Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E.

Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies

Sarkar M, Saha S.

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, Şahin U, Jansen KU.

Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?

Al-Kassmy J, Pedersen J, Kobinger G.

Invited Editorial: Despite COVID-19, Influenza Must Not Be Relegated to "Only the Sniffles"

Pawelec G.

Emerging Therapeutic Modalities against COVID-19

Malik S, Gupta A, Zhong X, Rasmussen TP, Manautou JE, Bahal R.

Efficacy of hydroxychloroquine and tocilizumab in patients with COVID-19: A single-center retrospective chart review

Roomi S, Ullah W, Ahmed F, Farooq S, Sadiq U, Chohan A, Jafar M, Saddique M, Khanal S, Watson R, Boigon M.

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2

Shahrajabian MH, Sun W, Cheng Q.

New anti-viral drugs for the treatment of COVID-19 instead of favipiravir

Aktaş A, Tüzün B, Aslan R, Sayin K, Ataseven H.

Risk of QTc prolongation with Chloroquine/Hyroxychloroquine and Azithromycin treatment for COVID-19: Quantification and precautions for a busy clinician

Mansuri Z, Adnan M, Motiwala F, Zafar MK, Jolly T, Jain S.

SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development

Olvera A, Noguera-Julian M, Kilpelainen A, Romero-Martín L, Prado JG, Brander C.

"Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies

Laskar P, Yallapu MM, Chauhan SC.

Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies

Mahmood Z, Alrefai H, Hetta HF, A Kader H, Munawar N, Abdul Rahman S, Elshaer S, Batiha GE, Muhammad K.

Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial

Xiao M, Tian J, Zhou Y, Xu X, Min X, Lv Y, Peng M, Zhang Y, Yan D, Lang S, Zhang Q, Fan A, Ke J, Li X, Liu B, Jiang M, Liu Q, Zhu J, Yang L, Zhu Z, Zeng K, Li C, Zheng Y, Wu H, Lin J, Lian F, Li X, Tong X.

Staying safe while waiting for the vaccine - what we need to do

Nabarro D, Atkinson J.

Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19

Sagardia LM, Daniels LM.

Lung Cancer Treatment in COVID-19-Positive Patients: Guidelines and Gestalt

Greenberg A, Anand G, Sinclair G.

Psychological Therapies and Psychoeducational Recommendations for Bipolar Disorder Treatment During COVID-19 Pandemic."

de Siqueira Rotenberg L, Nascimento C, Cohab Khafif T, Silva Dias R, Lafer B.

Hat Remdesivir Einfluss auf die Mortalität? : Schwer erkrankte COVID-19-Patienten

Schumacher B.

Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention

Tarek M, Savarino A.

Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials

Chen C, Pan K, Wu B, Li X, Chen Z, Xu Q, Li X, Lv Q.

[Occupational safety in the treatment of COVID-19 patients : Relevant laws and regulations for the treating personnel]

Mayr NP, Sernetz S, Heitzer F, Joner M, Tassani-Prell P.

Long-term effects of treatment for chronic nightmares: is imagery rehearsal therapy robust in the COVID-19 pandemic?

Sierro C, Leslie W, Putois B.

Impact of the novel coronavirus disease (COVID-19) on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure

Batool-Anwar S, Omobomi OS, Quan SF.

Volatile molecules for COVID-19: A possible pharmacological strategy?

Colalto C.

COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: a systematic review of cases

Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D.

Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19

Peña-Silva R, Duffull SB, Steer AC, Jaramillo-Rincon SX, Gwee A, Zhu X.

Hydroxychloroquine for COVID-19: Myths vs facts

Kumar S, Sil A, Das A.

Hydroxychloroquine treatment in COVID-19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China

Xue H, Liu Y, Luo P, Liu X, Qiu L, Liu D, Li J.

SARS-CoV-2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in COVID-19 Patients

Bradfute SB, Hurwitz I, Yingling AV, Ye C, Cheng Q, Noonan TP, Raval JS, Sosa NR, Mertz GJ, Perkins DJ, Harkins MS.

Drugs against SARS-CoV-2: What do we know about their mode of action?

Valle C, Martin B, Touret F, Shannon A, Canard B, Guillemot JC, Coutard B, Decroly E.

Re Facial aesthetic injections in clinical practice: Pretreatment and post-treatment consensus recommendations to minimise adverse outcome Region-specific changes in line with the Covid-19 pandemic

Goodman GJ, Liew S, Callan P, Hart S, Somia N, Sullivan J, Heydenrych I.

Repurposing of Kinase Inhibitors for Treatment of COVID-19

Weisberg E, Parent A, Yang PL, Sattler M, Liu Q, Liu Q, Wang J, Meng C, Buhrlage SJ, Gray N, Griffin JD.

COVID-19: should oral vaccination strategies be given more consideration?

Mehan A, Venkatesh A, Girish M.

After 62 years of regulating immunity, dexamethasone meets COVID-19

Cain DW, Cidlowski JA.

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

Bartsch SM, O'Shea KJ, Ferguson MC, Bottazzi ME, Wedlock PT, Strych U, McKinnell JA, Siegmund SS, Cox SN, Hotez PJ, Lee BY.

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Wang H, Zhang Y, Huang B, Deng W, Quan Y, Wang W, Xu W, Zhao Y, Li N, Zhang J, Liang H, Bao L, Xu Y, Ding L, Zhou W, Gao H, Liu J, Niu P, Zhao L, Zhen W, Fu H, Yu S, Zhang Z, Xu G, Li C, Lou Z, Xu M, Qin C, Wu G, Gao GF, Tan W, Yang X.

Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly?

ÖztÜrk G, Akbulut KG, GÜney Ş.

Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab

Iannetta M, Cesta N, Stingone C, Malagnino V, Teti E, Vitale P, De Simone G, Rossi B, Ansaldo L, Compagno M, Spalliera I, Di Lorenzo A, Landi D, Nicoletti CG, Marfia GA, Andreoni M, Sarmati L.

Global clinical trial mobilization for COVID-19: higher, faster, stronger

Beall RF, Hollis A.

Response to "Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment"

Shaw KS, Karagounis TK, Yin L, Gibbon G, Betensky RA, Lo Sicco KI, Femia AN.

Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study

Hosseini FS, Amanlou M.

Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results

Lopez A, Duclos G, Pastene B, Bezulier K, Guilhaumou R, Solas C, Zieleskiewicz L, Leone M.

What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results

Marcolino VA, Pimentel TC, Bar√£o CE.

Convalescent Plasma Therapy on Patients with Severe or Life-Threatening COVID-19: A Metadata Analysis

Rabelo-da-Ponte FD, Silvello D, Scherer JN, Ayala AR, Klamt F.

Clinical benefits of Tocilizumab in COVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia

Stephen S, Park YA, Chrysostomou A.

Convalescent plasma a clutch at straws in COVID-19 management! A systematic review and meta-analysis

Sarkar S, Soni KD, Khanna P.

Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted

Miyazawa D, Kaneko G.

Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study

Giacomelli A, Pagani G, Ridolfo AL, Bit LO, Conti F, Pezzati L, Bradanini L, Casalini G, Bassoli C, Morena V, Passerini S, Rizzardini G, Cogliati C, Ceriani E, Colombo R, Rusconi S, Gervasoni C, Cattaneo D, Antinori S, Galli M.

Low dose radiation therapy for COVID-19 pneumonia: brief review of the evidence

Metcalfe PE.

Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort

Karolyi M, Pawelka E, Mader T, Omid S, Kelani H, Ely S, Jilma B, Baumgartner S, Laferl H, Ott C, Traugott M, Turner M, Seitz T, Wenisch C, Zoufaly A.

Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation

Srivastava S, Verma S, Kamthania M, Kaur R, Badyal RK, Saxena AK, Shin HJ, Kolbe M, Pandey KC.

Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection

Huang ST, Lai HC, Lin YC, Huang WT, Hung HH, Ou SC, Lin HJ, Hung MC.

Chloroquine and COVID-19: Should We Care about Ototoxicity?

Monteiro EMR, Nascimento MFL, Brito TRC, Lima MC, Sefair LR, Pedrosa MM.

Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure

Basu D, Ghosh A, Subodh BN, Mattoo SK.

A Review of Remdesivir for COVID-19: Data to Date

Mehta M, Shyh G.

Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?

Manjunath BG, Tyagi D, Chaudhry D, Singh PK.

Study of the Adherence to continuous positive airway pressure Treatment in Patients with Obstructive Sleep Apnea Syndrome in the Confinement During the COVID-19 Pandemic

Del Campo F, López G, Arroyo CA, de Frutos JF, Crespo A, Cerezo-Hernández A, Álvaro TM, Ruiz T, Moreno F, Gutiérrez-Tobal GC, Hornero R, Álvarez D.

Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan

Tsai CC, Wang YC, Chiang TT, Chen IA, Chiu CH, Yang YS, Yeh KM, Chang FY.

Therapeutic plasma exchange resolving COVID-19 related ARDS

Lin JH, Lu CL, Wu HJ, Wang WJ.

Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines

Forman R, Anderson M, Jit M, Mossialos E.

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review

Jomah S, Asdaq SMB, Al-Yamani MJ.

Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study

Mukherjee S, Dasgupta S, Adhikary T, Adhikari U, Panja SS.

Clinical effectiveness of flucloxacillin delivery using an elastomeric device for outpatient parenteral antimicrobial therapy

Zhang Y, Ody YC, Davis L.

Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic

Papautsky EL, Hamlish T.

Clinical Outcomes Associated with Methylprednisolone in Mechanically Ventilated Patients with COVID-19

Nelson BC, Laracy J, Shoucri S, Dietz D, Zucker J, Patel N, Sobieszczyk ME, Kubin CJ, Gomez-Simmonds A.

Comment on Arshad et al: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

Varisco TJ, Johnson ML, Thornton D.

Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19

Laurence J, Mulvey JJ, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM.

Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan K, Katz N, Lepor NE, Vijay K, Carter H, Singh B, McCullough SP, Bhambi BK, Palazzuoli A, De Ferrari GM, Milligan G, Safder T, Tecson KM, Wang DD, McKinnon, O'Neill WW, Zervos M, Risch HA.

A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence)

Zheng K, Liao G, Lalu MM, Tinmouth A, Fergusson DA, Allan DS.

Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic (Sleep COVID-19): structured summary of a study protocol for a randomised controlled trial

Elder GJ, Alfonso-Miller P, Atkinson WCM, Santhi N, Ellis JG.

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

Koshak AE, Koshak EA, Mobeireek AF, Badawi MA, Wali SO, Malibary HM, Atwah AF, Alhamdan MM, Almalki RA, Madani TA.

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a r

Akram J, Azhar S, Shahzad M, Latif W, Khan KS.

Clinical trial to test the efficacy of melatonin in COVID-19

Acuña-Castroviejo D, Escames G, Figueira JC, de la Oliva P, Borobia AM, Acuña-Fernández C.

Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19

Liu M, Chen Z, Dai MY, Yang JH, Chen XB, Chen D, You H, Guo X, Leng Y, Yu L, Zhang ML, Wu X, Yang J, Gao C, Tenen DG, Chai L, Ai F.

Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study

Maiti S, Banerjee A.

AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Ivashchenko AA, Dmitriev KA, Vostokova NV, Azarova VN, Blinow AA, Egorova AN, Gordeev IG, Ilin AP, Karapetian RN, Kravchenko DV, Lomakin NV, Merkulova EA, Papazova NA, Pavlikova EP, Savchuk NP, Simakina EN, Sitdekov TA, Smolyarchuk EA, Tikhomolova EG, Yakubova EV, Ivachtchenko AV.

Seeds of hope in COVID-19 vaccine preliminary data

Stower H.

A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19

Wang X, Xie P, Sun G, Deng Z, Zhao M, Bao S, Zhou Y.

Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis

Li R, Li Y, Li B, Sun H, Liu X, Ge X, Liu Y, Yang J.

Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?

Schluenz LA, Ramos-Otero GP, Nawarskas JJ.

Correspondence on 'Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist' by Graef et al

Lo CH, Wang YH, Tsai CF, Chan KC, Li LC, Lo TH, Su CH, Wei JC.

Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al

Duarte-García A, Graef ER, Liew JW, Konig MF, Kim AH, Sparks JA.

Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design

Meyer-Almes FJ.

Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment

Xin S, Cheng X, Zhu B, Liao X, Yang F, Song L, Shi Y, Guan X, Su R, Wang J, Xing L, Xu X, Jin L, Liu Y, Zhou W, Zhang D, Liang L, Yu Y, Yu R.

Natural history of COVID-19 and current knowledge on treatment therapeutic options

Dos Santos WG.

The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients

Hamed MGM, Hagag RS.

Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation

Potere N, Di Nisio M, Rizzo G, La Vella M, Polilli E, Agostinone A, Spacone A, Di Carlo S, Costantini A, Abbate A, Porreca E, Parruti G.

Hydroxychloroquine in COVID-19: taking care of statistic to take care of patients

Brito-Azevedo A.

Re: Arshad S, Kilgore P, Chaudhry ZS et al. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Int J Infect Dis: 2020. Epub 2020 Jul 1 http://doi.org/10.1016/j.ijid.2020.06.099

Wiseman DM.

Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab

Langer-Gould A, Smith JB, Gonzales EG, Castillo RD, Garza Figueroa J, Ramanathan A, Li BH, Gould MK.

COVID-19: A review of the proposed pharmacological treatments

Lam S, Lombardi A, Ouanounou A.

Melatonin potentials against viral infections including COVID-19: current evidence and new findings

Juybari KB, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S.

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L.

Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP

Faheem M, Singh VK.

Possible Targets and Therapies of SARS-CoV-2 Infection

Sarkar K, Sil PC, Nabavi SF, Neagoe IB, Cismaru CA, Nabavi SM, Habtemariam S.

The Plausible role of Indian Traditional Medicine in combating Corona Virus (SARS-CoV 2): a mini-review

Adithya J, Nair B, Aishwarya S, Nath LR.

Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2

Thakur A, Tan SPF, Chan JCY.

Stem Cell Therapy for Covid-19: Possibilities and Challenges

Choudhery MS, Harris DT.

Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells

Ko M, Jeon S, Ryu WS, Kim S.

Prolonged use of internet and gaming among treatment seekers arising out of social restrictions related to COVID-19 pandemic

Higuchi S, Mihara S, Kitayuguchi T, Miyakoshi H, Ohi M, Maezono M, Nishimura K, Matsuzaki T.

Susceptibility to COVID-19 in patients treated with antimalarials: a population based study in Emilia-Romagna, Northern Italy

Salvarani C, Mancuso P, Gradellini F, Viani N, Pandolfi P, Reta M, Carrozzi G, Sandri G, Bajocchi G, Elena G, Muratore F, Boiardi L, Pipitone N, Cassone G, Croci S, Marata AM, Costantini M, Giorgi Rossi P.

Biologic drugs during COVID-19 outbreak

Montesu MA, Biondi G, Sotgiu G, Sucato F, Satta R.

Climate and COVID-19 pandemic: effect of heat and humidity on the incidence and mortality in world's top ten hottest and top ten coldest countries

Meo SA, Abukhalaf AA, Alomar AA, Al-Beeshi IZ, Alhowikan A, Shafi KM, Meo AS, Usmani AM, Akram J.

Association between the spread of COVID-19 and weather-climatic parameters

Carta MG, Scano A, Lindert J, Bonanno S, Rinaldi L, Fais S, Orr√π G.

Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy

De Giorgi A, Fabbian F, Di Simone E, Greco S, De Giorgio R, Zuliani G, Passaro A, Caselli E, Manfredini R; OUTCOME-INTMED-COV19 Study Collaborators.

Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence

Ren HW, Wu Y, Dong JH, An WM, Yan T, Liu Y, Liu CC.

Hospital reengineering against COVID-19 outbreak: 1-month experience of an Italian tertiary care center

Tosoni A, Rizzatti G, Nicolotti N, Di Giambenedetto S, Addolorato G, Franceschi F, Zileri Dal Verme L; Gemelli Against COVID-19 Clinician Team (GAC-19 CT) Study Group.

Corticosteroid therapy for patients with severe novel Coronavirus disease 2019

Ma Q, Qi D, Deng XY, Yuan GD, Tian WG, Cui Y, Yan XF, Wang DX.

Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management?

Orr√π B, Szekeres-Bartho J, Bizzarri M, Spiga AM, Unfer V.

Psychological support and the COVID-19 - A short report

Chen GF, Cheng YR, Ye L, Wang MW, Zhou MY, Zhang F, Chen J, Feng ZH.

Speculative clues on Myasthenia gravis and COVID-19

Scoppetta C, Casciato S, Di Gennaro G.

Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA)

Dar SA, Wahid M, Haque S, Almalki SS, Akhter N.

Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases

Gao Y, Qiu HB, Zhou S, Wang ZN, Zhang JC, Zhang ZL, Qian ZX, Wang HB, Yu SH, Luo YF, Wang YD, Liu Z, Wang WC, Jia M, Zhang LM, Zhang Y, Jin Y, Zhang Y, Liu Y, Zhou ZH, Su Y, Li HQ, Xiao WM, Huang K, He P, Li G, Fu ZH, Liu S, Lin NX, Cheng FJ.

Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic

Gluckman TJ, Wilson MA, Chiu ST, Penny BW, Chepuri VB, Waggoner JW, Spinelli KJ.

Unwavering Regulatory Safeguards for COVID-19 Vaccines

Shah A, Marks PW, Hahn SM.

Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

Mégarbane B, Scherrmann JM.

Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study

Kewan T, Covut F, Al-Jaghbeer MJ, Rose L, Gopalakrishna KV, Akbik B.

Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study

Mastroianni A, Greco S, Apuzzo G, De Santis S, Oriolo C, Zanolini A, Chidichimo L, Vangeli V.

Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report

Carannante N, Fiorentino G, Corcione A, Di Sarno R, Spatarella M, Maturo N, Fragranza F, Di Micco P.

Home-based traditional Chinese medicine nursing interventions for discharged patients with COVID-19: a rapid review of Chinese guidelines

Xu X, Shi YN, Wang RY, Liu T, Xu J, Mao W, Sun QH.

Potential Using of Fat-derived Stromal Cells in the Treatment of Active Disease, and also, in Both Pre- and Post-Periods in COVID-19

Copcu HE.

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review

Jeong GU, Song H, Yoon GY, Kim D, Kwon YC.

Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option?

Calderone A, Menichetti F, Santini F, Colangelo L, Lucenteforte E, Calderone V.

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomi

Huang YQ, Tang SQ, Xu XL, Zeng YM, He XQ, Li Y, Harypursat V, Lu YQ, Wan Y, Zhang L, Sun QZ, Sun NN, Wang GX, Yang ZP, Chen YK.

Triaging Spine Surgery and Treatment during the COVID-19 Pandemic

Rizkalla JM, Hotchkiss W, Clavenna A, Dossett A, Syed IY.

Postulated Adjuvant Therapeutic Strategies for COVID-19

Ferreira AO, Polonini HC, Dijkers ECF.

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh M, Shrestha R, Wu AA, Hughes RM, Burgess I, Caturegli P, Laeyendecker O, Quinn TC, Sullivan DJ, Shoham S, Redd AD, Bloch EM, Casadevall A, Tobian AAR.

Raising the Digital Profile of Facial Palsy: National surveys of patients' and clinicians' experiences of changing UK treatment pathways and views on future role of digital technology

Szczepura A, Holliday N, Neville C, Johnson K, Khan AJK, Oxford SW, Nduka C.

The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients

Kloc M, Ghobrial RM.

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19

Norinder U, Tuck A, Norgren K, Munic Kos V.

Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis

Jutzeler CR, Bourguignon L, Weis CV, Tong B, Wong C, Rieck B, Pargger H, Tschudin-Sutter S, Egli A, Borgwardt K, Walter M.

Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study

Kalligeros M, Shehadeh F, Atalla E, Mylona EK, Aung S, Pandita A, Larkin J, Sanchez M, Touzard-Romo F, Brotherton A, Shah R, Cunha CB, Mylonakis E.

Medication shortages during the COVID-19 pandemic: Saving more than COVID lives

Sen-Crowe B, McKenney M, Elkbuli A.

Role of Anesthesia Nurses in the Treatment and Management of Patients With COVID-19

Chen Q, Lan X, Zhao Z, Hu S, Tan F, Gui P, Yao S.

COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors

Ragnesola B, Jin D, Lamb CC, Shaz BH, Hillyer CD, Luchsinger LL.

Are BCG-induced non-specific effects adequate to provide protection against COVID-19?

Vashishtha VM.

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin

Anupama BK, Adhikari S, Chaudhuri D.

Treatment of Aortic Aneurysms During the COVID-19 Pandemic: Time to Abandon the NICE Guidelines

McGreevy DT, Hörer TM.

Response to "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated with COVID-19: A Theoretical Hypothesis and Early Clinical Experience"

Burger AM, D'Agostini M.

Managing the front-line treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma during the COVID-19 outbreak

de la Cruz-Benito B, Lázaro-Del Campo P, Ramírez-López A, de Soto-Álvarez T, Sánchez-Vadillo I, García-Pérez E, Dos Santos-Ortas A, Humala-Barbier K, López-de la Guía A, Casado-Abad G, Jiménez-Yuste V, Canales-Albendea MA.

Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Gouda AS, Mégarbane B.

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase

Xu Y, Jiang H.

Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19

Tang L, Jiang Y, Zhu M, Chen L, Zhou X, Zhou C, Ye P, Chen X, Wang B, Xu Z, Zhang Q, Xu X, Gao H, Wu X, Li D, Jiang W, Qu J, Xiang C, Li L.

Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs

Yu B, Li C, Chen P, Li J, Jiang H, Wang DW.

'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic

Barello S, Nania T, Dellafiore F, Graffigna G, Caruso R.

Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope

Shankar A, Dubey A, Saini D, Prasad CP.

The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation

Wang J, Peng Y, Xu H, Cui Z, Williams RO 3rd.

Convalescent plasma to treat COVID-19

Bloch EM.

COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection

Stauffer WM, Alpern JD, Walker PF.

Glucocorticoids save lives in COVID-19 patients

Deng CX.

We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?

Kersten DJ, Makaryus AN.

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M.

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects

Liu X, Cao W, Li T.

Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels

Xiang Z, Liu J, Shi D, Chen W, Li J, Yan R, Bi Y, Hu W, Zhu Z, Yu Y, Yang Z.

An overview of the expert consensus on the mental health treatment and services for major psychiatric disorders during COVID-19 outbreak: China's experiences

Xiang YT, Zhao N, Zhao YJ, Liu Z, Zhang Q, Feng Y, Yan XN, Cheung T, Ng CH.

COVID vaccine results pour in

Anti-IL-6Rs falter in COVID-19

Mullard A.

COVID-19 vaccine guidelines

Mullard A.

Hydroxychloroquine is no miracle cure for covid-19 infection -imaging and clinical course in an elderly female

Harsch IA, Skiba M, Lopatta E, Konturek PC.

Covid-19: Where are we on immunity and vaccines?

Mahase E.

Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production

Fintelman-Rodrigues N, Sacramento CQ, Ribeiro Lima C, Souza da Silva F, Ferreira AC, Mattos M, de Freitas CS, Cardoso Soares V, da Silva Gomes Dias S, Temerozo JR, Miranda MD, Matos AR, Bozza FA, Carels N, Alves CR, Siqueira MM, Bozza PT, Souza TML.

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

Ugarte-Gil MF, Konig MF, Korsten P, Berenbaum F, Kim AH, Sparks JA.

Convalescent plasma for COVID-19

Mucha SR, Quraishy N.

A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir

Joumaa H, Regard L, Carlier N, Chassagnon G, Alabadan E, Canouï E, L'honneur A, Rozenberg F, Burgel PR, Roche N.

High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia

Wiltshire E, Peña AS, MacKenzie K, Shaw G, Couper J.

N-acetycysteine: A potential therapeutic agent in COVID-19 infection

Jaiswal N, Bhatnagar M, Shah H.

Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2

Francini E, Miano ST, Fiaschi AI, Francini G.

Rethinking interleukin-6 blockade for treatment of COVID-19

Scherger S, Henao-Martínez A, Franco-Paredes C, Shapiro L.

Statins may be a key therapeutic for Covid-19

Gordon D.

SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial

Zheng F, Zhou Y, Zhou Z, Ye F, Huang B, Huang Y, Ma J, Zuo Q, Tan X, Xie J, Niu P, Wang W, Xu Y, Peng F, Zhou N, Cai C, Tang W, Xiao X, Li Y, Zhou Z, Jiang Y, Xie Y, Tan W, Gong G.

COVID-19: pharmacology and kinetics of viral clearance

Farina N, Ramirez GA, De Lorenzo R, Di Filippo L, Conte C, Ciceri F, Manfredi AA, Rovere-Querini P.

Vitamin D for COVID-19: a case to answer?

Martineau AR, Forouhi NG.

Were it business opportunities or hidden risks: Observations on clinical trials and marketing authorizations of Gilead Science's remdesivir in China

Yu X, Li N, Li Y.

Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration

Ayoub BM, Ramadan E, Ashoush N, Tadros MM, Hendy MS, Elmazar MM, Mousa SA.

Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm

Nadaroglu H.

Treatments for COVID-19: where are we now?

Mendes A.

Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series

Lee C, Ahn MY, Byeon K, Choi JP, Hahm C, Kim H, Kim S, Kim TH, Oh J, Oh DH.

Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication

Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee W, Ahn JH.

Smoking and COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers

Voinsky I, Gurwitz D.

Applicability of bedside ultrasonography for the diagnosis of deep venous thrombosis in patients with COVID-19 and treatment with low molecular weight heparin

Zhang P, Qu Y, Tu J, Cao W, Hai N, Li S, Qu P, Lv C, Guo R.

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schäfer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, Martinez DR, Bock KW, Minai M, Nagata BM, Hutchinson GB, Wu K, Henry C, Bahi K, Garcia-Dominguez D, Ma L, Renzi I, Kong WP, Schmidt SD, Wang L, Zhang Y, Phung E, Chang LA, Loomis RJ, Altaras NE, Narayanan E, Metkar M, Presnyak V, Liu C, Louder MK, Shi W, Leung K, Yang ES, West A, Gully KL, Stevens LJ, Wang N, Wrapp D, Dor

Early intubation and restrictive fluid management are key in the treatment of patients with moderate-severe COVID-19 pneumonitis

Ballin A, Bonvicini D, Vasques F, Bond O, Tiberio I.

COVID-19: The Immune Responses and Clinical Therapy Candidates

Zhand S, Saghaeian Jazi M, Mohammadi S, Tarighati Rasekhi R, Rostamian G, Kalani MR, Rostamian A, George J, Douglas MW.

The efficacy and safety of Chinese traditional medicine injections on patients with coronavirus disease 2019: A protocol for systematic review and meta analysis

Li Y, Xu H, Lang H, Li J, Bi L, Li Y, Dong L, Zhang L, Liang X, Zhu H.

Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges

Badgujar KC, Badgujar VC, Badgujar SB.

Teaching Old Drugs New Tricks: Statins for COVID-19?

Fajgenbaum DC, Rader DJ.

Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development

Ezzikouri S, Nourlil J, Benjelloun S, Kohara M, Tsukiyama-Kohara K.

MAY PHYTOTHERAPY WITH POLYPHENOLS SERVE AS A POWERFUL APPROACH FOR THE PREVENTION AND THERAPY TOOL OF NOVEL CORONAVIRUS DISEASE 2019 (COVID-19)?

Levy E, Delvin E, Marcil V, Spahis S.

Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy

Ammirati E, Travi G, Orcese C, Sacco A, Auricchio S, Frigerio M, Puoti M.

Novel Coronavirus Pneumonia Treatment With Traditional Chinese Medicine: Response Philosophy in Another Culture

Li Z, Han C, Huang H, Guo Z, Xu F.

COVID-19: Older drugs for a novel disease-Chloroquine, hydroxychloroquine, and possible Pentoxifylline-set to start the second innings?

Thangaraju P, Gurunthalingam MP, Varthya S, Venkatesan S, Thangaraju E.

Preventive and treatment strategies of COVID-19: From community to clinical trials

Sahu KK, Kumar R.

The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts

Khan I, Ahmed Z, Sarwar A, Jamil A, Anwer F.

Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts

Neupane K, Ahmed Z, Pervez H, Ashraf R, Majeed A.

The use of dexamethasone in the treatment of COVID-19

Lester M, Sahin A, Pasyar A.

A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection

Mayor-Ibarguren A, Busca-Arenzana C, Robles-Marhuenda Á.

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C.

Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach

Naz A, Shahid F, Butt TT, Awan FM, Ali A, Malik A.

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro

Clementi N, Criscuolo E, Diotti RA, Ferrarese R, Castelli M, Dagna L, Burioni R, Clementi M, Mancini N.

Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review

Barati F, Pouresmaieli M, Ekrami E, Asghari S, Ziarani FR, Mamoudifard M.

Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19

Sedokani A, Feizollahzadeh S.

Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothes

Schulze-Koops H, Krueger K, Vallbracht IV, Hasseli R, Skapenko A.

BET 1: The role of remdesivir in COVID-19 infection

Baombe JP.

Vitamin D Supplementation During the COVID-19 Pandemic

Siuka D, Pfeifer M, Pinter B.

Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection

Voisin O, Lorc'h EL, Mahé A, Azria P, Borie MF, Hubert S, Ménage E, Guillerm JC, Mourad JJ.

The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications

Khan S, Gionfriddo MR, Cortes-Penfield N, Thunga G, Rashid M.

Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2

Siddiqui AJ, Jahan S, Ashraf SA, Alreshidi M, Ashraf MS, Patel M, Snoussi M, Singh R, Adnan M.

Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application

Soto ME, Guarner-Lans V, Soria-Castro E, Manzano Pech L, Pérez-Torres I.

Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2

Shirvani E, Samal SK.

Treatment Impact on COVID-19 evolution in hemodialysis patients

Chawki S, Buchard A, Sakhi H, Dardim K, El Sakhawi K, Chawki M, Boulanger H, Kofman T, Dahmane D, Rieu P, Attaf D, Ahriz-Saksi S, Besson F, Boula R, Hafi A, Massoumi A, Diddaoui AZ, Fromentin L, Michaut P, Nebbad R, Desassis JF, Nicolet L, Ghazali A, Sohier-Attias J, Lamriben L, Adem A, Dupuis E, Rifard MK, Joly D, El Karoui K, Attias P; HD-CovIDF Study group.

The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19

Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N.

Corticosteroid, oseltamivir, and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019

Hu F, Yin G, Chen Y, Song J, Ye M, Liu J, Chen C, Song Y, Tang X, Zhang Y.

Drug interactions: a review of the unseen danger of experimental COVID-19 therapies

Hodge C, Marra F, Marzolini C, Boyle A, Gibbons S, Siccardi M, Burger D, Back D, Khoo S.

Closing the COVID-19 Psychological Treatment Gap for Cancer Patients in Alberta: Protocol for Implementation and Evaluation of Text4Hope-Cancer Care

Agyapong VIO, Hrabok M, Shalaby R, Mrklas K, Vuong W, Gusnowski A, Surood S, Greenshaw AJ, Nkire N.

Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin usage in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis

Pei L, Zhang S, Huang L, Geng X, Ma L, Jiang W, Li W, Chen D.

[Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness]

Vollaard A, Gieling EM, van der Linden PD, Sinha B, de Boer MGJ.

Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months

de Las Heras B, Saini KS, Boyle F, Ades F, de Azambuja E, Bozovic-Spasojevic I, Romano M, Capelan M, Prasad R, Pattu P, Massard C, Portera C, Saini ML, Singh BP, Venkitaraman R, McNally R, Leone M, Grande E, Gupta S.

The Development of COVID-19 Vaccines: Safeguards Needed

Lurie N, Sharfstein JM, Goodman JL.

Errors in Trial of Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19

Liu Z.

Correction to Data in Trial of Convalescent Plasma Treatment for COVID-19

Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease

Upadhyay S, Tripathi PK, Singh M, Raghavendhar S, Bhardwaj M, Patel AK.

Rapid Establishment of a COVID-19 Convalescent Plasma Program in a Regional Healthcare Delivery Network

Blackall D, Wulff S, Roettger T, Jacobs L, Lacasse A, Patri M, Zinser P, Pherez F, Jamkhana Z, Frey SE, Smith L, Goel R, Katz L.

Diagnostic and Treatment Strategies for COVID-19

Jamshaid H, Zahid F, Din IU, Zeb A, Choi HG, Khan GM, Din FU.

Dexamethasone nanomedicines for COVID-19

Lammers T, Sofias AM, van der Meel R, Schiffelers R, Storm G, Tacke F, Koschmieder S, Brümmendorf TH, Kiessling F, Metselaar JM.

Achieving HIV targets by 2030: the possibility of using debt relief funds for sustainable HIV treatment in sub-Saharan Africa

Abah RC.

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicenter, cohort study

Aliberti S, Radovanovic D, Billi F, Sotgiu G, Costanzo M, Pilocane T, Saderi L, Gramegna A, Rovellini A, Perotto L, Monzani V, Santus P, Blasi F.

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines

Kochhar S, Excler JL, Kim D, Robertson JS, Fast PE, Condit RC, Drew S, Wood D, Gurwith M, Klug B, Whelan M, Khuri-Bulos N, Mallett Moore T, Smith ER, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Electronic address: brightoncollaborationv3swg@gmail.com.

Should estrogen be used in the co-treatment of COVID-19 patients? What is the rationale?

Hamzaoglu K, Erel CT.

Response to "Should estrogen be used in the co-treatment of COVID-19 patients?"

Cano A, Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Mendoza N.

Clinical practice guidelines and experts' consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review

Li Y, Li J, Zhong D, Zhang Y, Zhang Y, Guo Y, Clarke M, Jin R.

Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges

Yang X, Liu Y, Liu Y, Yang Q, Wu X, Huang X, Liu H, Cai W, Ma G.

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro

Jo S, Kim S, Kim DY, Kim MS, Shin DH.

Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2

Kaur N, Singh R, Dar Z, Bijarnia RK, Dhingra N, Kaur T.

New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?

Gupta PK.

A Sound Approach: Hydroxychloroquine Reduces Mortality in Severe COVID-19

Zervos M, Arshad S, Kilgore P, Chaudhry ZS, Jacobsen G, Wang DD, Huitsing K, Brar I, Alangaden GJ, Ramesh MS, McKinnon JE, O'Neill W.

Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W, Mehta RS, Warner ET, Sikavi DR, Lo CH, Kwon S, Song M, Mucci LA, Stampfer MJ, Willett WC, Eliassen AH, Hart JE, Chavarro JE, Rich-Edwards JW, Davies R, Capdevila J, Lee KA, Lochlainn MN, Varsavsky T, Sudre CH, Cardoso MJ, Wolf J, Spector TD, Ourselin S, Steves CJ, Chan AT; COronavirus Pandemic Epidemiology Consortium.

Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method

Zhou L, Wang J, Liu G, Lu Q, Dong R, Tian G, Yang J, Peng L.

Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients

Patel K, Gooley TA, Bailey N, Bailey M, Hegerova L, Batchelder A, Holdread H, Dunleavy V, Downey T, Frisvold J, Megrath S, Pagarigan K, Szeto J, Rueda J, Islam A, Maree C, Nyatsatsang S, Bork SE, Lipke A, O'Mahony DS, Wagner T, Pulido J, Mignone J, Youssef S, Hartman M, Goldman JD, Pagel JM.

Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects

Sharun K, Tiwari R, Iqbal Yatoo M, Patel SK, Natesan S, Dhama J, Malik YS, Harapan H, Singh RK, Dhama K.

Medical education focus in published articles related to COVID-19

Aggarwal G, Aggarwal S, Robles J, Depasquale JR, Auseon A.

Transmission mode associated with coronavirus disease 2019: a review

Vella F, Senia P, Ceccarelli M, Vitale E, Maltezou H, Taibi R, Lleshi A, Venanzi Rullo E, Pellicanò GF, Rapisarda V, Nunnari G, Ledda C.

An emergency strategy for intensive care unit during COVID-19 outbreak in Chongqing, China

Deng W, Qi D, Wang DX.

SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential

Rat P, Olivier E, Dutot M.

The impact of COVID-19 on doctors' well-being: results of a web survey during the lockdown in Italy

De Sio S, Buomprisco G, La Torre G, Lapteva E, Perri R, Greco E, Mucci N, Cedrone F.

Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy

De Vito A, Geremia N, Fiore V, Princic E, Babudieri S, Madeddu G.

Severe COVID-19 patients with liver injury: a seven-case series

Li X, Zhang ZC, Zhang PL.

Breast surgeons updating on the thresholds of COVID-19 era: results of a multicenter collaborative study evaluating the role of online videos and multimedia sources on breast surgeons education and training

Marcasciano M, Kaciulyte J, Mori FLR, Lo Torto F, Barellini L, Loreti A, Fanelli B, De Vita R, Redi U, Marcasciano F, Di Cesare F, Dal Prà G, Conversi A, Elia L, Montemari G, Vaia N, Bernini M, Sordi S, Luridiana G, D'Ermo G, Monti M, De Luca A, Ricci F, Mazzocchi M, Gentilucci M, Greco M, Losco L, Valdatta LA, Raposio E, Giudice G, Maruccia M, Di Benedetto G, Cigna E, Casella D, Ribuffo D.

Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors

Ranjbar A, Jamshidi M, Torabi S.

Clinical characteristics and outcomes of 2019-nCoV-infected patients admitted at different time periods

Liu WR, Zuo GJ, Qin Y.

From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality

Abbasi Pashaki P, Habibi Roudkenar M, Rahim F, Ebrahimi A.

Clinical outcomes of 201 neonates born to mothers with COVID-19: a systematic review

Yoon SH, Kang JM, Ahn JG.

Role of 5G-powered remote robotic ultrasound during the COVID-19 outbreak: insights from two cases

Yu RZ, Li YQ, Peng CZ, Ye RZ, He Q.

The Uncertain Role of Corticosteroids in the Treatment of COVID-19

Liou TG, Adler FR, Hatton ND.

The Uncertain Role of Corticosteroids in the Treatment of COVID-19-Reply

Song Y, Wu C, Chen X.

Searching for COVID-19 treatments: First, do no harm

Guharoy R, Krenzelok E.

The Uncertain Role of Corticosteroids in the Treatment of COVID-19

Ellsworth GB, Glesby MJ, Gulick RM.

Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system

Jarvis MA, Hansen FA, Rosenke K, Haddock E, Rollinson C, Rule S, Sewell G, Hughes A, Feldmann H.

Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study

Eimer J, Vesterbacka J, Svensson AK, Stojanovic B, Wagrell C, Sönnerborg A, Nowak P.

Is vitamin C an effective agent for the prevention of COVID-19 and treatment of severe infection in the ICU?

İzol Torun AN.

Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit

Sun D.

Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19

Koker O, Demirkan FG, Kayaalp G, Cakmak F, Tanatar A, Karadag SG, Sonmez HE, Omeroglu R, Aktay Ayaz N.

Population Data-Driven Formulation of a COVID-19 Therapeutic

Campbell HR, Cecil RP, Lodder R.

COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19

Strohbehn GW, Heiss BL, Rouhani SJ, Trujillo JA, Yu J, Kacew AJ, Higgs EF, Bloodworth JC, Cabanov A, Wright RC, Koziol A, Weiss A, Danahey K, Karrison TG, Edens CC, Ventura IB, Pettit NN, Patel B, Pisano J, Strek ME, Gajewski TF, Ratain MJ, Reid PD.

Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19

Lofgren SMM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanshi R, Schwartz IS, Silverman M, Chagla Z, Kelley LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R.

An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19

McGregor R, Chauss D, Freiwald T, Yan B, Wang L, Nova-Lamperti E, Zhang Z, Teague H, West EE, Bibby J, Kelly A, Malik A, Freeman AF, Schwartz D, Portilla D, John S, Lavender P, Lionakis MS, Mehta NN, Kemper C, Cooper N, Lombardi G, Laurence A, Kazemian M, Afzali B.

CoVaccine HT‚Ñ¢ adjuvant potentiates robust immune responses to recombinant SARS-CoV-2 Spike S1 immunisation

Haun BK, Lai CY, Williams CA, Wong TA, Lieberman MM, Pessaint L, Andersen-Elyard H, Lehrer AT.

Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2

Kim J, Mukherjee A, Nelson D, Jozic A, Sahay G.

Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy

Shabalin IG, Czub MP, Majorek KA, Brzezinski D, Grabowski M, Cooper DR, Panasiuk M, Chruszcz M, Minor W.

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schaefer A, Dinnon K, Garcia-Sastre A, Krammer F, Baric RS, Palese P.

Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2

Banerjee S, Majumder K, Gutierrez GJ, Gupta D, Mittal B.

Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh

Bhuyan MA, Al Mahtab M, Ashab E, Haque MJ, Hoque SMM, Faizul Huq A, Islam MA, Choudhury N, Alia RA, Mahtab M, Khan MSI, Akbar SM.

Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review

Kwon S, Lee W, Jin C, Jang I, Jung WS, Moon SK, Cho KH.

Is the traditional Chinese herb "Artemisia annua" possible to fight against COVID-19?

Law S, Leung AW, Xu C.

Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials

Ji HL, Liu C, Zhao RZ.

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus

Leung AK, McMillan T, Human A, Lam JM.

Letter to the Editor: COVID-19 and the Neurosurgical Treatment of Idiopathic Normal Pressure Hydrocephalus: Shall We Continue to Postpone "Non-emergent" Surgical Procedures?

La Corte E, Palandri G.

Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review

Mhatre S, Srivastava T, Naik S, Patravale V.

In-Hospital Delays for Acute Stroke Treatment Delivery during the COVID-19 Pandemic

Katsanos AH, de Sa Boasquevisque D, Ahmed Al-Qami M, Shawawrah M, McNicoll-Whiteman R, Gould L, Van Adel B, Sahlas DJ, Ng KKH, Perera K, Sharma M, Oczkowski W, Pikula A, Shoamanesh A, Catanese L.

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis

Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A; COVID-19 Global Rheumatology Alliance.

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Rayman G, Lumb AN, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney HC, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients

Esquivel D, Mishra R, Soni P, Seetharaman R, Mahmood A, Srivastava A.

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse

Morrisette T, Lodise TP, Scheetz MH, Goswami S, Pogue JM, Rybak MJ.

Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19

Zou L, Dai L, Zhang X, Zhang Z, Zhang Z.

Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemia

Capucci A, Santarelli A, Bartolomei M, Paolizzi C, Biagetti C, Dappozzo A, Piovaccari G.

A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients

Gao G, Wang A, Wang S, Qian F, Chen M, Yu F, Zhang J, Wang X, Ma X, Zhao T, Zhang F, Chen Z.

Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19)

Ruamviboonsuk P, Lai TYY, Chang A, Lai CC, Mieler WF, Lam DSC.

A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population

Martinez Navarro W, Ly L, Segal MS, Shukla AM.

Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19

Wiwanitkit V.

Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): A link between antiviral and anticancer mechanisms?

Alonso DF, Farina HG.

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19

Mazzitelli M, Davoli C, Scaglione V, Fusco P, La Gamba V, Matera G, Trecarichi EM, Torti C.

Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: a systematic review and meta-analysis of 40 studies and 25,278 patients

Shao M, Li X, Liu F, Tian T, Luo J, Yang Y.

COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials

Chakraborty R, Parvez S.

[Pharmacological treatment in uncertainty times: Hydroxychloroquine/chloroquine use in the COVID-19 treatment]

Mayayo-Vicente S, Rodriguez Salvanés F, Gallego-Arenas A, Sánchez-Gómez LM, Ruiz-López M, Sierra García B, Jurado-López A, Arriola-Bolado P, Cervera Cano M, Novella-Arribas B.

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?

Nicolau DV, Bafadhel M.

Hydroxychloroquin for COVID-19 Why was so much hype?

Pahlajani D.

Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin and Combination in Patients Hospitalized with COVID-19"

Atkinson JG.

Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?

d'Arminio Monforte A, Tavelli A, Bai F, Marchetti G, Cozzi-Lepri A.

Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19

Rosenberg ES, Holtgrave DR, Udo T.

Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19

Kara E, Demirkan K, Unal S.

In silico Study of Azithromycin, Chloroquine and Hydroxychloroquine and their Potential Mechanisms of Action against SARS-CoV-2 Infection

Braz HLB, de Moraes Silveira JA, Marinho AD, de Moraes MEA, de Moraes Filho MO, Monteiro HSA, Jorge RJB.

Lactoferrin as potential preventative and treatment for COVID-19

Chang R, Ng TB, Sun WZ.

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

Sanchis-Gomar F, Lavie CJ, Morin DP, Perez-Quilis C, Laukkanen JA, Perez MV.

Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach

Kanhed AM, Patel DV, Teli DM, Patel NR, Chhabria MT, Yadav MR.

Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma

Capecchi PL, Lazzerini PE.

COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

Teh CL, Cheong YK, Wan Musa WR, Wan Mohd Akbar SA, Mat Husin N, Gun SC.

Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al

Mathian A, Amoura Z.

Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma

Potere N, Di Nisio M, Cibelli D, Scurti R, Frattari A, Porreca E, Abbate A, Parruti G.

Rational use of tocilizumab in COVID-19

Jain S, Sharma SK.

Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials

Arab-Zozani M, Hassanipour S, Ghoddoosi-Nejad D.

Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in Covid-19

Portmann-Baracco A, Bryce-Alberti M, Accinelli RA.

Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?

Rafiullah M.

Low-cost devices to prevent SARS-CoV-2 infection during open and laparoscopic surgery

Cabrera Vargas LF, Torregrosa L, Guevara O, Pedraza M, Carrera JA, Villarreal RA, Vinck EE, Cabrera L, Ferrada P, Chen H.

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial

Nanni O, Viale P, Vertogen B, Lilli C, Zingaretti C, Donati C, Masini C, Monti M, Serra P, Vespignani R, Grossi V, Biggeri A, Scarpi E, Galardi F, Bertoni L, Colamartini A, Falcini F, Altini M, Massa I, Gaggeri R, Martinelli G.

ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial

Wilkinson T, Dixon R, Page C, Carroll M, Griffiths G, Ho LP, De Soyza A, Felton T, Lewis KE, Phekoo K, Chalmers JD, Gordon A, McGarvey L, Doherty J, Read RC, Shankar-Hari M, Martinez-Alier N, O'Kelly M, Duncan G, Walles R, Sykes J, Summers C, Singh D; ACCORD Collaborators.

[Surgical treatment of non-small cell lung cancer in the conditions of a new coronavirus infection pandemic (COVID-19)]

Allakhverdyan AS.

Determination of an optimal control strategy for vaccine administration in COVID-19 pandemic treatment

Libotte GB, Lobato FS, Platt GM, Silva Neto AJ.

Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience

Hu Y, Wang T, Hu Z, Wang X, Zhang Z, Li L, Peng P.

Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak

Veenstra J, Buechler CR, Robinson G, Chapman S, Adelman M, Tisack A, Dimitrion P, Todter E, Kohen L, Lim HW.